Regina M. Barden

Unicompartmental knee arthroplasty. Clinical experience at 6- to 10-year followup.

Sixty-two consecutive cemented modular unicompartmental knee arthroplasties in 51 patients were studied prospectively. At surgery, the other compartments had at most Grade 2 chondromalacia. The average age of the patients at arthroplasty was 68 years (range, 51-84 years). One patient was lost to followup and 10 died with less than 6 years followup. The average followup of the remaining 51 knees was 7.5 years (range, 6-10 years). The preoperative Hospital for Special Surgery knee score of 55 points (range, 30-79 points) improved to 92 points (range, 60-100 points) at followup; 78% (40 knees) had excellent and 20% (10 knees) had good results. The mean range of motion at followup was 120 degrees with 26 knees (51%) having range of motion greater than 120 degrees. One patient underwent revision surgery for retained cement, one patient underwent knee manipulation, and one patient underwent revision surgery at 7 years for opposite compartment degeneration and pain. Radiographically, 26 knees (51%) had at least one partial radiolucency. There were no complete femoral radiolucencies, but there were three complete tibial radiolucencies, all less than 2 mm. No component was loose as seen on radiographs. At final followup, five of the opposite compartments (10%) and three of the patellofemoral joints (6%) had some progressive radiographic joint space loss; this was less than a 25% loss in all but one knee component that was revised. At 6- to 10-years followup, cemented unicompartmental knee arthroplasty yielded excellent clinical and radiographic results. The 10-year survival using radiographic loosening or revision as the end point was 98%. Using stringent selection criteria, unicompartmental knee replacement can yield excellent results and represents a superb alternative to total knee replacement.

Patellar component failure in cementless total knee arthroplasty.

One hundred twenty-two total knee arthroplasties were performed with porous ingrowth fixation of the patellar component between February 1984 and February 1987. Twelve subsequently have experienced fatigue fracture of the patellar component at the peg-plate junction. All fractured patellar components demonstrated excellent ingrowth and fixation of the porous titanium fiber mesh-peg surfaces with no ingrowth into the porous plate underlying the polyethylene patellar surface. While the initial group of 122 arthroplasties was only slightly greater than one-third male, the preponderance of patellar fractures was in males (ten of 12). Patients with patellar component failure were on average younger and heavier and had a greater range of knee motion than the index group. The average time from implantation to recognition of fracture was 24 months. Biomechanical analysis of the force system about a domed patella demonstrated that loading of the patellofemoral joint results in eccentric loading of the dome surface. Peg fixation not accompanied by fixation of the overlying plate allows these high eccentric forces to load the peg-plate junction in shear with consequent fatigue at the peg-plate junction. These results indicate that the shear forces are sufficiently high to warrant caution in the use of peg-plate systems in which peg ingrowth without plate ingrowth occurs.(ABSTRACT TRUNCATED AT 250 WORDS)

Long-term followup of the Miller-Galante total knee replacement

One hundred seventy-two consecutive cemented Miller-Galante-I total knee arthroplasties in 155 patients were compared with 109 consecutive cemented Miller-Galante-II total knee arthroplasties in 92 patients. The average followup was 11 years (range, 8–15 years) and 9 years (range, 8–10 years), respectively. Of the 172 Miller-Galante-I arthroplasties, there have been 21 revisions; 15 patellar revisions; two included femoral revisions attributable to abrasion. Six additional well-fixed femoral and tibial components were revised: two for early instability, one for pain, one for periprosthetic fracture, and two for infection. No component had aseptic loosening or osteolysis. Using revision or loosening of any components as the end point, the Kaplan-Meier 10-year survivorship was 84.1% ± 4.1%. Of the 109 Miller-Galante-II arthroplasties, there have been no component revisions, no aseptic loosening, and no osteolysis. Using revision or loosening of any components as the end point, the Kaplan-Meier 10-year survivorship was 100%. The Miller-Galante knee systems showed excellent fixation with no loosening and no osteolysis at as many as 15 years. Additionally, there have been no component revisions for late instability at as many as 15 years. Finally, the high prevalence of patellofemoral complications with the Miller-Galante-I design has been obviated with the Miller-Galante-II design.

Problems with cementless total knee arthroplasty at 11 years followup.

One hundred two patients with 131 consecutive cementless total knee arthroplasties that retained the posterior cruciate ligament were followed up prospectively. The average age of the patients was 58 years (range, 32–75 years). The mean followup on the surviving knee arthroplasties was 11 years (range, 7–16 years). The patellar component was metal-backed in the first 112 (85%) knees, cementless all-polyethylene in the last 17 (13%) knees, and two knees had a prior patellectomy. Forty-four metal-backed patellar components (48%) were revised; nine were loose, and 35 had polyethylene wear through. Thirteen femoral components (12%) were revised because of femoral abrasion from a failed metal-backed patellar component. No other femoral component was revised, loose, or had osteolysis develop. Nine (8%) tibial components had failure of ingrowth; eight have been revised. Partial radiolucencies occurred in 53% of the tibias. Thirteen (12%) small osteolytic lesions developed, all around screws or screw holes in the tibial components. At an average of 11 years followup, cementless fixation yielded mixed results: cementless femoral fixation was excellent and metal-backed patellar components had a 48% patellar revision rate. Cementless tibial components had an 8% aseptic loosening rate and a 12% incidence of small osteolytic lesions. Based on these results, the authors have abandoned cementless fixation in total knee arthroplasty.

Revision total knee arthroplasty with a cemented posterior-stabilized or constrained condylar prosthesis: A minimum 3-year and average 5-year follow-up study☆

The results of 57 revision total knee arthroplasties performed for aseptic failure between 1984 and 1992 with a cemented posterior-stabilized or constrained condylar prosthesis were reviewed at follow-up examinations at a minimum of 36 and an average of 62 months (range, 36-120 months). The reason for revision was aseptic loosening of 1 or both components in 32 knees (56%), instability in 16 knees (28%), polyethylene wear and osteolysis in 4 knees (7%), supracondylar femur fracture in 2 knees (4%), and a failed allograft, pain, and arthrofibrosis in 1 knee each (5% total). The average age of the patients at the time of the revision was 74 years (range, 38-90), and the original diagnosis for the majority of patients was osteoarthritis (74%). All of the revision prostheses were cemented posterior stabilized or constrained condylar-type implants. Bone deficiencies were grafted with cancellous allograft in contained defects and cortical allograft in noncontained defects. Five knees were reconstructed with allograft-prosthesis composites. The average modified Hospital for Special Surgery knee score improved from 49 to 82 (100 points possible) at final follow-up evaluation (P < 0.001). Seventy-nine percent of knees were graded as good or excellent. Kaplan-Meier survivorship analysis predicted 94%+/-6.2% survival at 40 months and 75%+/-25% at 99 months. There were 4 clinical failures, 3 of which were related to residual instability in patients with a posterior-stabilized prosthesis. Complications (3 knees) were exclusively related to the extensor mechanism. Radiographically, overall knee alignment improved from 0.3 degrees varus to 3.0 degrees valgus. Fifty-six percent of tibial components were placed in slight varus alignment. Radiolucent lines occurred in 33% of knees, but there were no complete or progressive radiolucencies. Radiolucent lines were more prevalent adjacent to press-fit intramedullary femoral stems compared with cemented stems (P < .02), but the difference did not correlate with clinical or radiographic failure. The median bone defect score, as proposed by the Knee Society Committee on Bone Defects, was significantly greater in knees that were revisions of a failed cemented total knee arthroplasty compared with revision of a failed cementless total knee arthroplasty (P = .02) but was not correlated with clinical or radiographic outcome (P > .05).

Posterior cruciate ligament-retaining total knee arthroplasty in patients with rheumatoid arthritis.

7We previously reported the minimum eight-year follow-up results of cruciate-retaining total knee arthroplasty in a consecutive series of seventy-two knees in patients with rheumatoid arthritis. In the present study, we evaluated the longer-term outcomes after twenty to twenty-five years of follow-up. Since the publication of our original study, ten knees have been revised: three because of periprosthetic fracture, three because of infection, two because of patellofemoral failure, and two because of posterior instability. The rate of implant survival at twenty years after surgery was 69% (95% confidence interval [CI], 56% to 79%) with revision for any reason as the end point, 81% (95% CI, 69% to 89%) with femoral or tibial component revision for any reason as the end point, and 93% (95% CI, 83% to 97%) with posterior instability as the end point. These long-term results demonstrate that posterior cruciate ligament insufficiency with instability was rarely the cause of failure following cruciate-retaining total knee arthroplasty in patients with rheumatoid arthritis.

Miller—Galante unicompartmental knee arthroplasty at 2- to 5-year follow-up evaluations

A consecutive series of 62 Miller-Galante (Zimmer, Warsaw, IN) unicompartmental knee arthroplasties were evaluated. Patients had unicompartmental degenerative arthritis or osteonecrosis, a sagittal plane deformity of 15 degrees or less, and minimal patellofemoral involvement. The average age was 69, with osteoarthritis in 85% and osteonecrosis in 15%. Ninety-five percent were medial and 5% lateral compartment replacements. The Hospital for Special Surgery knee score averaged 56 +/- 11 before surgery and 96 +/- 5 at the final follow-up evaluation, with an average postoperative pain score of 48 +/- 2. Three patients suffered intra-operative or immediate postoperative tibial plateau fractures without apparent sequelae, one patient required a postoperative manipulation under anesthesia, and one patient required an arthroscopic debridement for retained cement in the posterior capsular space. Limb alignment was corrected to within 5 degrees of the neutral mechanical axis in 77%, with 19% undercorrected and 3% overcorrected. Seventy percent of knees showed at least a single radiolucent line. Complete radiolucent lines were noted about three tibial components (6%) and progressive partial radiolucency was noted about four additional components (8%).

Cemented and ingrowth fixation of the Miller-Galante prosthesis. Clinical and roentgenographic comparison after three- to six-year follow-up studies.

One hundred thirty-nine cemented and 132 cementless Miller-Galante total knee prostheses were followed between three and six years (average, 43-44 months). The fixation technique was based on patient age, bone quality, and ability to delay full-weight bearing. Clinical follow-up studies were possible on 116 cemented knees. Fifteen knees were lost because of death before the three-year follow-up study, and eight knees required component removal. One hundred twenty-three cementless knees were available for clinical follow-up studies; there were three deaths, and six failures required component removal. No cemented failure was due to fixation, and three cementless failures were due to lack of tibial ingrowth in two and pain of undetermined etiology in one. Preoperative knee scores were slightly significant with cemented knees averaging 48 points and cementless knees averaging 52 points. A similar significant difference was maintained at the final follow-up study. No significant differences were noted for pain, limp, or support scores. Average range of motion was similar in the two groups. Radiolucent lines about the femoral component were rare. Cementless tibial radiolucencies were partial in up to 20% of examined zones, and complete tibial tray radiolucency was seen in only three patients. No correlation between radiolucency and knee scores was seen.

The Prosthesis-Bone Interface Adjacent to Tibial Components Inserted without Cement. Clinical and Radiographic Follow-up at Nine to Twelve Years*

We evaluated the radiographic and functional status of a one-piece composite tibial component, designed to be inserted without cement, that was developed and used only at our institution. Thirty-six patients (thirty-seven knees) were managed with the component between November 1981 and September 1983, and none were lost to follow-up. When they were last seen, thirty-four (92 per cent) of the thirty-seven knees had a well fixed tibial component, both clinically and radiographically. Eight patients (eight knees; 22 per cent) died. Eleven patients (eleven knees; 30 per cent) had a revision at an average of sixty-five months (range, four to ninety-five months) postoperatively. The reason for the revision was failure of a metal-backed patellar component in three knees, excessive wear of the polyethylene of the tibial component in one, a hematogenous infection in four, aseptic loosening of the tibial component in two, and chronic synovitis in one. The remaining seventeen patients (eighteen knees; 49 per cent) were seen for clinical and radiographic follow-up at an average of eleven years (range, nine to twelve years) after the operation. With removal of the implant as the end point, the cumulative rate of survival was 83 per cent at fifty-six months and 67 per cent at 108 months. Some of the failures were secondary to features of the prosthetic design that currently are considered to be inadequate, including a metal-backed patellar component and carbon- fiber-reinforced polyethylene. In the twenty-six knees in which the prosthesis had been retained, the implant was stable and the prosthesis-bone interface was unchanged as seen radiographically at the time of the most recent follow-up examination. This finding demonstrates that a porous ingrowth surface is capable of providing a secure interface for biological fixation over the long term.

Heterotopic Ossification Prophylaxis After Total Hip Arthroplasty: Randomized Trial of 400 vs 700 cGy

BACKGROUND Heterotopic ossification (HO) is a known complication following total hip arthroplasty. Radiation is an effective prophylaxis, but an optimal protocol has yet to be determined. We performed a randomized, double-blinded clinical trial in high-risk patients to determine the efficacy of 400 vs 700 cGy doses of radiation. METHODS One hundred forty-seven patients undergoing total hip arthroplasty and at high risk for HO at an urban medical center were randomized to receive either a single 400 or 700 cGy dose of radiation postoperatively. High risk was defined as a diagnosis of diffuse idiopathic skeletal hyperostosis, hypertrophic osteoarthritis, ankylosing spondylitis, or history of previous HO. Radiation was administered on the first or second postoperative day. A single blinded reviewer graded radiographs taken immediately postoperatively and at a minimum of 6 months postoperatively using the Brooker classification. Progression was defined as an increase in Brooker classification. Operative data including surgical approach, implant fixation, revision surgery, and postoperative range of motion data were also collected. RESULTS A significantly greater portion of patients who received the 400 cGy dose demonstrated progression of HO than patients who received the 700 cGy dose. There were no wound complications. No preoperative factors were associated with a higher rate of progression. Patients who progressed had less flexion on physical examination than patients who did not progress, but this was not clinically significant. CONCLUSION Seven hundred centigray was superior to 400 cGy in preventing HO formation following total hip arthroplasty in high-risk patients and may be the more effective treatment in this population. Further studies comparing 700 cGy to dosages between 400 and 700 cGy may help to clarify if a more optimal dose can be identified.